Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia

NCT00557778 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00557778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00557778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2007
Completion date
September 30, 2010
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with dyslipidemia